Stocks and Investing
by (remove) : Nathan Weinstein
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Nathan Weinstein
RSSJSONXMLCSV
Mon, August 15, 2022
Tue, July 12, 2022
Tue, March 29, 2022
Tue, November 16, 2021
Mon, November 15, 2021
Wed, September 22, 2021
Thu, September 9, 2021
Tue, August 17, 2021
Thu, July 8, 2021
Tue, June 29, 2021
Thu, March 4, 2021
Mon, January 25, 2021
Thu, October 8, 2020
Wed, September 16, 2020
Wed, September 2, 2020
Wed, August 19, 2020
Wed, May 6, 2020
Mon, May 4, 2020
Mon, March 23, 2020
Thu, October 31, 2019
Fri, February 28, 2014
Wed, October 30, 2013
Wed, October 16, 2013
Fri, December 7, 2012
Mon, July 9, 2012

Nathan Weinstein Maintained (VNRX) at Strong Buy with Decreased Target to $6 on, Aug 15th, 2022


Published on 2024-10-27 22:40:14 - WOPRAI, Nathan Weinstein
  Print publication without navigation


Nathan Weinstein of Aegis Capital, Maintained "VolitionRx Limited" (VNRX) at Strong Buy with Decreased Target from $9 to $6 on, Aug 15th, 2022.

Nathan, nor any peers, have made any analyst calls on VNRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources